| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 132.722.840 $ | 191,38 | 80.665.304 | |||||||
| United States Treasury Bills | B 0 06/25/26 | DBT | 912797TE7 | Long | Börsenkurs (Stufe 1) | 64.450.058 $ | 92,93 | 65.000.000 | |
| Plains GP Holdings LP | Plains GP Holdings LP LTD PARTNR INT A | EC | 72651A207 | Long | Börsenkurs (Stufe 1) | 30.892.901 $ | 44,55 | 1.272.360 | |
| Achieve Life Science Inc | Achieve Life Science Inc COM | EC | 004468500 | Long | Börsenkurs (Stufe 1) | 3.482.466 $ | 5,02 | 2.151.179 | |
| Phathom Pharmaceuticals Inc | Phathom Pharmaceuticals Inc COM | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 2.915.108 $ | 4,20 | 262.386 | |
| Delcath Systems Inc. | Delcath Systems Inc. COM NEW | EC | 24661P807 | Long | Börsenkurs (Stufe 1) | 2.423.249 $ | 3,49 | 261.126 | |
| Abeona Therapeutics Inc. | Abeona Therapeutics Inc. COM NEW | EC | 00289Y206 | Long | Börsenkurs (Stufe 1) | 2.241.532 $ | 3,23 | 500.342 | |
| Celldex Therapeutics Inc. | Celldex Therapeutics Inc. COM NEW | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 2.188.490 $ | 3,16 | 68.994 | |
| Milestone Pharmaceuticals Inc | Milestone Pharmaceuticals Inc COM | EC | 59935V107 | Long | Börsenkurs (Stufe 1) | 1.792.622 $ | 2,58 | 1.506.405 | |
| Oculis Holding AG | Oculis Holding AG ORDINARY SHARES | EC | CH1242303498 | Long | Börsenkurs (Stufe 1) | 1.772.676 $ | 2,56 | 66.667 | |
| LeonaBio Inc. | LeonaBio Inc. COM | EC | 04746L203 | Long | Börsenkurs (Stufe 1) | 1.534.588 $ | 2,21 | 149.279 | |
| Corcept Therapeutics Inc. | Corcept Therapeutics Inc. COM | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 1.522.227 $ | 2,19 | 37.763 | |
| Kyverna Therapeutics Inc | Kyverna Therapeutics Inc COM | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 1.493.905 $ | 2,15 | 173.106 | |
| Inventiva SA | Inventiva SA ADS | EC | 46124U107 | Long | Börsenkurs (Stufe 1) | 1.264.973 $ | 1,82 | 227.923 | |
| Viridian Therapeutics Inc | Viridian Therapeutics Inc COM | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 1.099.878 $ | 1,59 | 56.231 | |
| Aquestive Therapeutics Inc | Aquestive Therapeutics Inc COM | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 972.258 $ | 1,40 | 234.279 | |
| VOR BIOPHARMA INC | Vor Biopharma Inc. COM NEW | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 954.618 $ | 1,38 | 53.510 | |
| Orchestra BioMed Holdings Inc | Orchestra BioMed Holdings Inc COM | EC | 68572M106 | Long | Börsenkurs (Stufe 1) | 932.395 $ | 1,34 | 219.387 | |
| Zevra Therapeutics Inc | Zevra Therapeutics Inc COM NEW | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 897.013 $ | 1,29 | 96.246 | |
| Compass Pathways plc | Compass Pathways plc SPONSORED ADS | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 879.558 $ | 1,27 | 159.052 | |
| Telesat Canada /Telesat LLC | TELSAT 5.625 12/06/26 144A | DBT | 87952VAR7 | Long | Modellwert (Stufe 2) | 800.000 $ | 1,15 | 1.000.000 | |
| Trevi Therapeutics Inc | Trevi Therapeutics Inc COM | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 780.365 $ | 1,13 | 65.412 | |
| Ocular Therapeutix Inc | Ocular Therapeutix Inc COM | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 762.300 $ | 1,10 | 90.000 | |
| Sab Biotherapeutics Inc | Sab Biotherapeutics Inc COM NEW | EC | 78397T202 | Long | Börsenkurs (Stufe 1) | 717.091 $ | 1,03 | 187.230 | |
| Upstream Bio Inc | Upstream Bio Inc COM | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 700.137 $ | 1,01 | 77.793 | |
| Eyepoint Inc. | Eyepoint Inc. COM NEW | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 689.950 $ | 0,99 | 53.526 | |
| 4D Molecular Therapeutics Inc | 4D Molecular Therapeutics Inc COM | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 655.703 $ | 0,95 | 70.430 | |
| Palisade Bio Inc | Palisade Bio Inc COM | EC | 696389402 | Long | Börsenkurs (Stufe 1) | 612.500 $ | 0,88 | 350.000 | |
| Zealand Pharma As | Zealand Pharma As DKK1 | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 568.783 $ | 0,82 | 12.330 | |
| KALARIS THERAPEUTICS INC | Kalaris Therapeutics Inc. COM | EC | 482929106 | Long | Börsenkurs (Stufe 1) | 504.448 $ | 0,73 | 87.426 | |
| Immunic Inc. | Immunic Inc. COM | EC | 4525EP101 | Long | Börsenkurs (Stufe 1) | 487.215 $ | 0,70 | 438.932 | |
| Coherus Oncology Inc. | Coherus Oncology Inc. COM | EC | 19249H103 | Long | Börsenkurs (Stufe 1) | 427.807 $ | 0,62 | 253.140 | |
| Akero Therapeutics Inc | Akero Therapeutics Inc | EC | 009CVR044 | Long | Schätzwert (Stufe 3) | 426.634 $ | 0,62 | 145.609 | |
| Corvus Pharmaceuticals Inc | Corvus Pharmaceuticals Inc COM | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 296.140 $ | 0,43 | 20.242 | |
| Ovid Therapeutics Inc | Ovid Therapeutics Inc COM | EC | 690469101 | Long | Börsenkurs (Stufe 1) | 290.405 $ | 0,42 | 130.813 | |
| ARTIVA BIOTHERAPEUTICS INC | Artiva Biotherapeutics Inc. COM | EC | 04317A107 | Long | Börsenkurs (Stufe 1) | 149.601 $ | 0,22 | 23.230 | |
| CONNECT BIOPHARMA HOLDINGS LTD | Connect Biopharma Holdings Limited SHS | EC | KYG235491019 | Long | Börsenkurs (Stufe 1) | 139.843 $ | 0,20 | 53.375 | |
| Chinook Therapeutics Inc | Chinook Therapeutics Inc SHS | EC | 169CVR016 | Long | Schätzwert (Stufe 3) | 2.500 $ | 0,00 | 25.000 | |
| Eiger BioPharmaceuticals Inc | Eiger BioPharmaceuticals Inc | EC | 28249U204 | Long | Schätzwert (Stufe 3) | 900 $ | 0,00 | 90.000 | |
| MILESTONE PHARMACE WTS | MILESTONE PHARMACE WTS | EC | Long | Schätzwert (Stufe 3) | 4 $ | 0,00 | 3.685.948 | ||
| JASPER THERAPEUTIC WTS | JASPER THERAPEUTIC WTS | EC | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 609.053 | ||
| WTS - TENAYA THERAPEUTICS | WTS - TENAYA THERAPEUTICS | EC | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 560.000 | ||
| QUOIN PHARMACEUTIC WTS | QUOIN PHARMACEUTIC WTS | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 139.580 | ||
| 132.722.840 $ | 191,38 | 80.665.304 |